- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Covid-19: PGIMER conducts study to confirm persistence of antibodies in recovered patients
The study is an extension of the plasma therapy trial which has already been conducted at 39 hospitals across the country.
Chandigarh: In order to ensure whether plasma therapy is effective in treating covid-19 patients, the premier Postgraduate Institute of Medical Education and Research (PGIMER) has started a study to contemplate how long covid-19 antibodies can persist in recovered patients.The study is an extension of the plasma therapy trial which has already been conducted at 39 hospitals across the...
Chandigarh: In order to ensure whether plasma therapy is effective in treating covid-19 patients, the premier Postgraduate Institute of Medical Education and Research (PGIMER) has started a study to contemplate how long covid-19 antibodies can persist in recovered patients.
Sanchari Chattopadhyay has pursued her M.A in English and Culture Studies from the University of Burdwan, West Bengal. She likes observing cultural specificities and exploring new places.